Gapping down
In reaction to earnings/guidance:
LESL -20.1%, DPZ -11.7%, WNS -5.1%, NOK -4.6%, FOR -3.6%, MMC -2.5%, KMI -2.3% (also expects a 2% bump in 2024 dividends), OZK -2.2% (also approves $200 mln repurchase plan), NVS -2.2%, KEY -2%, BX -2%, FNB -1.8%, DHI -1.7%, ALK -1.5%
Other news:
AGEN -38.7% (announces end-of-phase-2 meeting outcomes and topline interim phase 2 data for BOT/BAL in MSS colorectal cancer)
BYND -13.1% (has engaged with bondholders for restructuring talks, according to WSJ)
SWIM -2.3% (in sympathy with weak LESL guidance)
GEHC -2.2% (to acquire clinical artificial intelligence business from Intelligent Ultrasound)
PFG -2.1% (reports June AUM)
VALN -2% (VALN and PFE complete primary vaccination series of Lyme disease vaccine candidate VLA15)
AUNA -1.8% (launches first oncology insurance in Mexico)
RF -1.4% (increases dividend)
VIGL -1.2% (update following a Type C Meeting with the U.S. FDA to its clinical development strategy for its IGNITE clinical trial)